Continuous Glucose Monitor System Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers

How Are the key drivers contributing to the expansion of the continuous glucose monitor system market?
The upward trend in the incidence of diabetes is projected to fuel the expansion of the continuous glucose monitor system market. Defined by elevated blood sugar levels due to the body's failure to efficiently generate or utilize insulin, diabetes is a persistent health issue. The surge in diabetes cases can be mainly associated with rising obesity rates, unhealthy eating habits, lack of physical activity, and an aging demographic. Continuous glucose monitoring (CGM) systems provide instant glucose measurements, assisting in diabetes management by identifying trends and alerting to irregular levels. It helps optimize blood sugar control, lessening the frequent poking of fingers for tests. As of June 2024, the National Health Service-a UK government agency-reported that in 2023, the NHS discovered an additional 549,000 individuals in England who are likely to get type 2 diabetes. This surged the total count of people diagnosed with non-diabetic hyperglycemia, or pre-diabetes, from GPs to 3,615,330. This figure represents a significant surge from the previous year's total of 3,065,825-an almost 20% increase. As such, the rising prevalence of diabetes acts as a catalyst for the growth of the continuous glucose monitor system market.

Get Your Continuous Glucose Monitor System Market Report Here:
https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitor-system-global-market-report

What growth opportunities are expected to drive the continuous glucose monitor system market's CAGR through 2034?
Over the last few years, the market size for the continuous glucose monitor (CGM) system has experienced rapid growth. It is projected to increase from $8.83 billion in 2024 to $9.67 billion in 2025 with a compound annual growth rate of 15.4%. This historic growth can be linked to several factors such as the increase in the aging population, heightened awareness around diabetes management, growth in disposable income, heightened investments in research and development, and a surge in healthcare spending.

The industry for continuous glucose monitor (CGM) systems is poised for imminent expansion in the coming years, predicted to bloat to a hefty $17.00 billion by 2029, with a compound annual growth rate (CAGR) of 15.1%. This predicted surge over the forecasting timeline is being linked to a variety of factors such as growing incidence of diabetes, increase in obesity cases, amplified socio-economic shifts, proliferation of clinical trials, and intensified urbanisation. Upcoming trends for this stretch include synchronization with smart devices, heightened use of artificial intelligence (AI), non-invasive tracking alternatives, augmentation of wearable technology, the upswing of telemedicine, and the advent of remote healthcare solutions.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20732&type=smp

What are the emerging trends shaping the future of the continuous glucose monitor system market?
Leading firms in the continuous glucose monitor system market are prioritising the development of advanced over-the-counter continuous glucose monitors (CGMs) to improve their accessibility and broaden their base among non-prescription users. An over-the-counter (OTC) continuous glucose monitor (CGM) provides a vehicle for consumers to autonomously monitor their glucose levels in real-time, without requiring medical prescription. For example, in September 2024, U.S-based medical appliance corporation, Abbott Laboratories, released Lingo in the United States. Tailored to non-diabetic adults, Lingo provides users with the ability to monitor glucose, lending essential insights into the impact of diet and fitness on overall well-being. The device, which can be worn for up to 14 days, bolsters Abbott's approach to penetrate the expanding market demographic interested in prediabetes management and health-conscious living, completely eliminating the need for a prescription.

Which growth-oriented segments of the continuous glucose monitor system market are leading the industry's development?
The continuous glucose monitor system market covered in this report is segmented -

1) By Component: Transmitters, Receivers, Sensor
2) By Technology: Real Time Continuous Glucose Monitoring, Intermittently Scanned Continuous Glucose Monitoring
3) By Demography: Child Population, Adult Population
4) By Application: Type-1 Diabetes, Type-2 Diabetes, Gestational Diabetes
5) By End-User: Diagnostics Centers, Hospitals, Clinics, Intensive Care Unit (ICUs), Home Healthcare

Subsegments:
1) By Transmitters: Bluetooth-Enabled Transmitters, Wireless Transmitters
2) By Receivers: Dedicated Devices (CGM Receiver), Smartphone-Based Receivers, Cloud-Connected Receivers
3) By Sensor: Enzyme-Based Sensors, Non-Enzyme-Based Sensors, Electrochemical Sensors

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20732

What regions are leading the charge in the continuous glucose monitor system market?
North America was the largest region in the continuous glucose monitor (CGM) system market in 2024. The regions covered in the continuous glucose monitor system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What companies are at the forefront of innovation in the continuous glucose monitor system market?
Major companies operating in the continuous glucose monitor system market are Abbott Corporation, Medtronic PLC, Murata Manufacturing Co. Ltd., Dexcom Inc., Sinocare Inc., Tandem Diabetes Care Inc., Ascensia Diabetes Care Holdings AG, Glooko Inc., DarioHealth Corp., Menarini Diagnostics SRL, Senseonics Holdings Inc., WaveForm Technologies Inc., Medtrum Technologies Inc., Biolinq Incorporated, Ultrahuman Inc., GlySens Incorporated, Glucotrack, EOFLOW CO. LTD., Nemaura Medical Inc., Meiqi Medical Equipment, Nipro Diagnostics UK Limited

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20732&type=smp

What Is Covered In The Continuous Glucose Monitor System Global Market Report?

•Market Size Forecast: Examine the continuous glucose monitor system market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the continuous glucose monitor system market for a structured understanding.
•Key Players Overview: Analyze major players in the continuous glucose monitor system market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the continuous glucose monitor system market.
•Segment Contributions: Evaluate how different segments drive overall growth in the continuous glucose monitor system market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the continuous glucose monitor system market.
•Industry Challenges: Identify potential risks and obstacles affecting the continuous glucose monitor system market.
•Competitive Landscape: Review strategic developments in the continuous glucose monitor system market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.